Update on extended release quetiapine fumarate in schizophrenia and bipolar disorders

Update on extended release quetiapine fumarate in schizophrenia and bipolar disorders

Nizar El-KhaliliAlpine Clinic, Lafayette, IN, USAAbstract: The atypical antipsychotic quetiapine fumarate is available both as an immediate release (IR) and as an extended release (XR) formulation allowing flexibility of dosing for individual patients. Approved uses of quetiapine XR include the trea...

Full description

Bibliographic Details
Main Author:	El-Khalili N
Format:	Article
Language:	English
Published:	Dove Medical Press 2012-11-01
Series:	Neuropsychiatric Disease and Treatment
Online Access:	http://www.dovepress.com/update-on-extended-release-quetiapine-fumarate-in-schizophrenia-and-bi-a11479

Similar Items

The management of schizophrenia: focus on extended-release quetiapine fumarate
by: Peuskens J
Published: (2011-09-01)

Role of extended release quetiapine in the management of bipolar disorders
by: Rayan K Al Jurdi, et al.
Published: (2010-02-01)

Effects of once-daily extended release quetiapine fumarate on patient-reported outcomes in patients with generalized anxiety disorder
by: Endicott J, et al.
Published: (2012-07-01)

Pharmacokinetic evaluation of quetiapine fumarate controlled release hybrid hydrogel: a healthier treatment of schizophrenia
by: Muhammad Akhlaq, et al.
Published: (2018-01-01)

A 3-Week, Open Label Study to Evaluate the Efficacy and Safety of Extended Release Quetiapine Fumarate in the Treatment of Agitation in Patients with Schizophrenia
by: Koh, Ong Hui, et al.
Published: (2013)

Update on quetiapine in the treatment of bipolar disorder: results from the BOLDER studies
by: Prashant Gajwani, et al.
Published: (2007-01-01)

Quetiapine extended‐release vs olanzapine for Japanese patients with bipolar depression: A Bayesian analysis
by: Taro Kishi, et al.
Published: (2019-09-01)

Formulation and evaluation of buccoadhesive quetiapine fumarate tablets
by: Appa Rao Potu, et al.
Published: (2012-06-01)

The efficacy and safety of quetiapine in patients with bipolar disorder quetiapine in practice evaluation program (IPEP)
by: Filippou Rita, et al.
Published: (2006-02-01)

Electrochemical Studies for the Determination of Quetiapine Fumarate and Olanzapine Antipsychotic Drugs
by: Manal A. El-Shal
Published: (2013-08-01)

Branch retinal vein occlusion associated with quetiapine fumarate
by: Siang Lim, et al.
Published: (2011-08-01)

Effect of Polymers and Permeation Enhancers in the Release of Quetiapine Fumarate Transdermal Patch through the Dialysis Membrane
by: Mullaicharam Bhupathyraaj, et al.
Published: (2022-05-01)

Quetiapine monotherapy for bipolar depression
by: Michael E Thase
Published: (2008-03-01)

Formulation and pharmaceutical development of quetiapine fumarate sustained release matrix tablets using a QbD approach
by: Gavan Alexandru, et al.
Published: (2017-03-01)

Quetiapine fumarate augmentation for patients with a primary anxiety disorder or a mood disorder: a pilot study
by: Chen Yi-Chih, et al.
Published: (2012-09-01)

Quetiapine N-oxide&#8211;fumaric acid (2/1)
by: Jin Shen, et al.
Published: (2012-06-01)

Real-World Economic Outcomes of Brexpiprazole and Extended-Release Quetiapine Adjunctive Use in Major Depressive Disorder
by: Seetasith A, et al.
Published: (2019-12-01)

Lurasidone, olanzapine, and quetiapine extended‐release for bipolar depression: A systematic review and network meta‐analysis of phase 3 trials in Japan
by: Taro Kishi, et al.
Published: (2020-12-01)

Medication adherence and utilization in patients with schizophrenia or bipolar disorder receiving aripiprazole, quetiapine, or ziprasidone at hospital discharge: A retrospective cohort study
by: Berger Ariel, et al.
Published: (2012-08-01)

TITRIMETRIC AND SENSITIVE SPECTRO-PHOTOMETRIC METHODS FOR THE ASSAY OF QUETIAPINE FUMARATE IN PHARMACEUTICAL FORMULATIONS
by: Nagaraju Rajendraprasad, et al.
Published: (2011-03-01)

Quetiapine more effective than placebo for depression in bipolar I and II disorder.
by: Goodwin, G
Published: (2007)

Maintenance treatment of adolescent bipolar disorder: open study of the effectiveness and tolerability of quetiapine
by: Milin Robert, et al.
Published: (2009-02-01)

Convulsive syncope related to a small dose of quetiapine in an adolescent with bipolar disorder
by: Lai J, et al.
Published: (2017-07-01)

The role of paliperidone extended release for the treatment of bipolar disorder
by: Marino J, et al.
Published: (2012-04-01)

Comparison of tolerability between quetiapine and haloperidol in schizophrenia
by: Naba Raj Koirala, et al.
Published: (2012-12-01)

Long-term mood/antidepressant effects of quetiapine extended-release formulation: an open-label, non-controlled extension study in Japanese patients with bipolar depression
by: Shigenobu Kanba, et al.
Published: (2019-06-01)

Central Composite Optimization of Glycerosomes for the Enhanced Oral Bioavailability and Brain Delivery of Quetiapine Fumarate
by: Randa Mohammed Zaki, et al.
Published: (2022-07-01)

Safety and efficacy of rapid dose administration of quetiapine in bipolar mania
by: Hatim, A., et al.
Published: (2006)

The Influence of Prenatal Exposure to Quetiapine Fumarate on the Development of Dopaminergic Neurons in the Ventral Midbrain of Mouse Embryos
by: Walaa F. Alsanie, et al.
Published: (2022-10-01)

Spectrophotometric determination of quetiapine fumarate in pharmaceuticals and human urine by two charge-transfer complexation reactions
by: Vinay K.B., et al.
Published: (2012-01-01)

Comparative Evaluation of Quetiapine Plus Lamotrigine Versus Quetiapine Monotherapy in Bipolar Depression: A Randomized Placebo Controlled Trial (CEQUEL)
by: Geddes, J, et al.
Published: (2014)

EXTRACTIVE SPECTROPHOTOMETRIC DETERMINATION OF QUETIAPINE FUMARATE IN PHARMACEUTICALS AND HUMAN URINE USING CALMAGITE AS AN ION-PAIR REAGENT
by: NAGARAJU RAJENDRAPRASAD, et al.
Published: (2011-09-01)

Efficacy and tolerability of clozapine versus quetiapine in treatment-resistant schizophrenia
by: Mitesh Kumar, et al.
Published: (2017-01-01)

Neurobiology of schizophrenia and bipolar disorder
by: Mφller Hans-Jórgen
Published: (2008-04-01)

Pareidolia in Schizophrenia and Bipolar Disorder
by: Eid G. Abo Hamza, et al.
Published: (2021-12-01)

Bipolar disorder: an update
by: Kim Outhoff
Published: (2017-08-01)

Update on bipolar disorder
by: Shehan Williams, et al.
Published: (2011-06-01)

Bipolar disorder update
by: Goodwin, G
Published: (2007)

Retrospective analysis of factors associated with quetiapine dosage in the acute and subsequent six-month maintenance treatment of bipolar disorders
by: Zhang L, et al.
Published: (2013-04-01)

Olanzapine-induced neuroleptic malignant syndrome in a patient with bipolar affective disorder: Does quetiapine holds the solution?
by: Praveen Tripathi, et al.
Published: (2013-01-01)